No Link Between Striatal Dopaminergic Axons and Dopamine Transporter Imagingin Parkinson’s Disease




Honkanen Emma A., Saari Laura, Orte Katri, Gardberg Maria, Noponen Tommi, Joutsa Juho, Kaasinen Valtteri

PublisherWiley-Blackwell Publishing Ltd.

2019

Movement Disorders

34

10

1562

1566

5

0885-3185

1531-8257

DOIhttps://doi.org/10.1002/mds.27777

10.1002/mds.27777

https://research.utu.fi/converis/portal/detail/Publication/41652649



Background:Brain dopamine transporter binding hasbeen considered a possible biomarker for nigrostriataldegeneration in PD.Objective:To investigate whether dopamine trans-porter binding is associated with the number of dopa-minergic neurites in the putamen.

Methods:Tyrosine hydroxylase–positive nervefiberswere counted from postmortem putamen sections takenfrom 14 parkinsonism patients who had been scannedwith dopamine transporter single-photon emission com-puted tomography antemortem. Fiber counts were cor-related with putamen dopamine transporter binding andSN neuron counts.

Results:The putamen dopamine transporter specificbinding ratio did not correlate with the putamen tyrosinehydroxylase–positive axon counts (r = 0.00;P= 1.0; PDpatients: r = 0.07;P= 0.86). The nigra neuron counts had a positive correlation with the putamen tyrosinehydroxylase–positive axon counts.

Conclusions:Striatal dopamine transporter imagingdoes not associate with axonal nor somal loss of thenigrostriatal neurons in PD. It may reflect dopaminergicactivity rather than number of surviving neurons or theirstriatal projection axons.


Last updated on 2024-26-11 at 22:33